grouped according to hepatic functional reserve, patients with more severe liver damage (grade C) had a lower polymorphonuclear cell zinc value (mean (SD) 0*86 (0.24) nmol/mg protein) than patients with grade A (1-44 (0.43) nmollmg protein, p<001) or grade B liver damage (1.08 (0.30) nmol/mg protein, p<005), or control subjects (1.26 (0.28) nmol/ mg protein, p<0-001). The polymorphonuclear cell zinc value did not correlate with other indices of zinc status. The mononuclear cell zinc value was normal in all patients and was unrelated to hepatic damage. The erythrocyte zinc value and carbonic anhydrase activity were raised in alcoholic patients only. Since the polymorphonuclear cell zinc concentration is low in human experimental zinc deficiency and also correlates with tissue zinc, we suggest that our results provide evidence ofprogressive leucocyte zinc depletion in patients with liver disease.
since different leucocyte subpopulations have varying zinc concentrations. ' This study was undertaken to assess whether there is evidence of zinc depletion in patients with alcoholic and non-alcoholic liver disease of varying severity by using a more extensive series of parameters to assess zinc status. We have measured the zinc content of pure Mononuclear and polymorphonuclear cells were separated from 10 ml non-fasting venous blood and assayed for zinc using graphite furnace atomic absorption spectrophotometry. 8 Purity of the isolated cells was assessed by non-specific esterase staining of cytocentrifuge smears and was always >95%. Viability was quantitated using trypan blue and was >90%.8 Precision of the leucocyte zinc assay was 3-8% within-batch (n=6) and 9-8% between-batch (n=8). Recovery of added zinc was 99 2-100 8%.8
PLASMA AND ERYTHROCYTE ZINC Five millilitres of blood were centrifuged and the plasma removed. Erythrocytes were washed three times in zinc-free saline and lysed with an equal volume of zinc-free water. An aliquot of this lysate was then diluted one in 10 with water, and the remainder was used for haemoglobin and carbonic anhydrase assays. Both plasma and diluted erythrocyte lysates were further diluted one in 15 with water and aspirated directly for zinc assay by flame atomic absorption.'0 Precision was 1 8% within-batch (n=5) and 6-6% between-batch (n=23). Commercial reference serum and an external quality assurance scheme were used to check accuracy.
II ERYTHROCYTE CARBONIC ANHYDRASE
Haemoglobin was removed from erythrocyte lysates as follows: 1 ml of lysate was mixed for one minute with 0-2 ml toluene, and centrifuged at 2225 g for 20 minutes at 4°C. The toluene layer and membranous interface were then discarded. At 4°C, 0-2 ml lysate was mixed for exactly one minute with 0-2 ml 40% (v/v) ethanol and 0-1 ml chloroform, both kept at -20°C, and then centrifuged at 13000 g for five minutes.
Carbonic anhydrase esterase activity was measured in the haemoglobin-free lysates by the conversion of p-nitrophenyl-acetate to pnitrophenol.'2 Precision of this assay was 6-8% (n= 10). The ratios of the two major isoenzymes of carbonic anhydrase (CAI and CAII) were quantitated by HPLC.'3 Identification of the peaks corresponding to the isoenzymes was confirmed using commercially purified human carbonic anhydrase isoenzymes (Sigma Chemical Co Ltd, Poole).
In addition, plasma albumin and bilirubin concentrations, prothrombin time ratios, and differential leucocyte counts were measured by routine methods. 
STATISTICAL METHODS
Differences between data sets were compared using Student's t test. Correlations were determined using the Spearman rank test. Differences were taken to be significant when p<0 05.
Results are expressed as mean (SD).
Results
The mean (SD) plasma zinc concentration was 8-56 [tmol/l in non-alcoholic patients and 7-52 [tmol/l in alcoholic patients, both of which were significantly lower than in control subjects (12-69 (1-40) iimol/l, p<0 001), shown in Table I .
Significant correlations were found between plasma zinc and albumin values (r=0-92, p<0 001 in non-alcoholic patients; r=0-77, p<0 01 in alcoholics).
The mean polymorphonuclear cell zinc concentration in alcoholic patients was not low (Table I ) but when these patients were subgrouped according to the degree of hepatic functional reserve,9 those with grade C (severe) liver damage (group 1, n= 7) had lower concentrations than those in whom liver damage was less severe (group 2, grades A and B, n=6). The polymorphonuclear cell zinc concentration in group 1 was mean (SD) 0-88 (0 19) nmol/mg protein compared with 1-53 (0-47) nmol/mg protein in group 2 (p<0 02), and 1-26 (0-28) nmol/mg protein in controls (p<0-02), shown in Figure 1 .
The same was also true of non-alcoholic patients. The group as a whole did not have a reduced mean polymorphonuclear cell zinc concentration (Table I) but when patients were subgrouped into group 1 (six grade B patients and three grade C patients) and group 2 (seven grade A patients), group 1 had lower polymorphonuclear cell zinc concentrations than group 2 (0-93 (0-23) compared with 1-36 (0-40) nmol/mg protein respectively, p<0-02) and control subjects (p<0-02, Fig 1) . The results from both alcoholic and non-alcoholic patients were also combined and grouped according to the grading of hepatic functional reserve (Table II 
